The case pertains to a Company Petition filed by the Liquidator of Adamas India Pharmaceuticals Private Limited under Section 59(7) of the Insolvency and Bankruptcy Code, 2016, seeking a direction for the dissolution of the Corporate Person/Company. The company, a subsidiary of Adamas Pharmaceuticals Inc., U.S.A., initiated voluntary liquidation proceedings. The management proposed terminating business activities and initiating members' voluntary winding up. The Board of Directors decided to voluntarily liquidate the Company on March 20, 2018, and executed a declaration as required under Section 59(3) of the IBC, 2016. A Special Resolution of the Members of the corporate person was obtained on April 02, 2018.
Adamas India Pharmaceuticals Pvt Ltd, a subsidiary of Adamas Pharmaceuticals Inc., U.S.A., was incorporated on 04.05.2007. Its authorized capital was Rs.5,00,000, divided into 50,000 equity shares of Rs.10 each. The main objects included pharmaceutical research and development. The management proposed terminating business activities and initiating members' voluntary winding up. The Board decided to voluntarily liquidate the Company on March 20, 2018, and executed a declaration under Section 59(3) of the IBC, 2016. A Special Resolution was obtained on April 02, 2018. The Company informed the ROC and IBBI about the Special Resolution on April 05, 2018. Public announcements were made in newspapers on April 04, 2018. The Liquidator informed various departments and received
…Sign in to view the parties.
Adamas India Pharmaceuti…
The Board of Directors…
The case pertains to a Company Petition filed by the Liquidator of Adamas India Pharmaceuticals Private Limited under Section 59(7) of the Insolvency and Bankruptcy Code, 2016, seeking a direction for the dissolution of the Corporate Person/Company. The company, a subsidiary of Adamas Pharmaceuticals Inc., U.S.A., initiated voluntary liquidation proceedings. The management proposed terminating business activities and initiating members' voluntary winding up. The Board of Directors decided to voluntarily liquidate the Company on March 20, 2018, and executed a declaration as required under Section 59(3) of the IBC, 2016. A Special Resolution of the Members of the corporate person was obtained on April 02, 2018.
Adamas India Pharmaceuticals Pvt Ltd, a subsidiary of Adamas Pharmaceuticals Inc., U.S.A., was incorporated on 04.05.2007. Its authorized capital was Rs.5,00,000, divided into 50,000 equity shares of Rs.10 each. The main objects included pharmaceutical research and development. The management proposed terminating business activities and initiating members' voluntary winding up. The Board decided to voluntarily liquidate the Company on March 20, 2018, and executed a declaration under Section 59(3) of the IBC, 2016. A Special Resolution was obtained on April 02, 2018. The Company informed the ROC and IBBI about the Special Resolution on April 05, 2018. Public announcements were made in newspapers on April 04, 2018. The Liquidator informed various departments and received
…Adamas India Pharmaceuti…
The Board of Directors…